| Producing nitric oxide by pulsed electrical discharge in air for portable inhalation therapy B Yu, S Muenster, AH Blaesi, DB Bloch, WM Zapol Science Translational Medicine 7 (294), 294ra107-294ra107, 2015 | 65 | 2015 |
| Development of a portable mini-generator to safely produce nitric oxide for the treatment of infants with pulmonary hypertension B Yu, M Ferrari, G Schleifer, AH Blaesi, M Wepler, WM Zapol, DB Bloch Nitric Oxide 75, 70-76, 2018 | 16 | 2018 |
| Detection and removal of impurities in nitric oxide generated from air by pulsed electrical discharge B Yu, AH Blaesi, N Casey, G Raykhtsaum, L Zazzeron, R Jones, ... Nitric Oxide 60, 16-23, 2016 | 14 | 2016 |
| Expandable fibrous dosage forms for prolonged drug delivery AH Blaesi, N Saka Materials Science and Engineering: C 120, 110144, 2021 | 12 | 2021 |
| 3D-micro-patterned fibrous dosage forms for immediate drug release AH Blaesi, N Saka Materials Science and Engineering: C 84, 218-229, 2018 | 12 | 2018 |
| Determination of the mechanical properties of solid and cellular polymeric dosage forms by diametral compression AH Blaesi, N Saka International Journal of Pharmaceutics 509 (1-2), 444-453, 2016 | 12 | 2016 |
| Melt-processed polymeric cellular dosage forms for immediate drug release AH Blaesi, N Saka Journal of Controlled Release 220, 397-405, 2015 | 12 | 2015 |
| Fibrous dosage forms by wet 3D-micro-patterning: Process design, manufacture, and drug release rate AH Blaesi, N Saka European Journal of Pharmaceutics and Biopharmaceutics 130, 345-358, 2018 | 11 | 2018 |
| Microstructural effects in drug release by solid and cellular polymeric dosage forms: A comparative study AH Blaesi, N Saka Materials Science and Engineering: C 80, 715-727, 2017 | 9 | 2017 |
| Continuous manufacture of polymeric cellular dosage forms AH Blaesi, N Saka Chemical Engineering Journal 320, 549-560, 2017 | 7 | 2017 |
| On the exfoliating polymeric cellular dosage forms for immediate drug release AH Blaesi, N Saka European Journal of Pharmaceutics and Biopharmaceutics 103, 210-218, 2016 | 7 | 2016 |
| Expandable, dual-excipient fibrous dosage forms for prolonged delivery of sparingly-soluble drugs AH Blaesi, N Saka International Journal of Pharmaceutics 615, 120396, 2022 | 6 | 2022 |
| Characterization of the electrochemical oxidation of glucose on Pt nanoparticle catalysts in pH neutral phosphate buffer solution AH Blaesi, CR Buie ECS Transactions 33 (40), 41, 2011 | 6 | 2011 |
| Solid-solution fibrous dosage forms for immediate delivery of sparingly-soluble drugs: Part 2. 3D-micro-patterned dosage forms AH Blaesi, N Saka Materials Science and Engineering: C 129, 110211, 2021 | 5 | 2021 |
| Fibrous dosage form AH Blaesi, N Saka US Patent 11,129,798, 2021 | 5 | 2021 |
| Solid-solution fibrous dosage forms for immediate delivery of sparingly-soluble drugs: Part 1. Single fibers AH Blaesi, N Saka Materials Science and Engineering: C 109, 109918, 2020 | 5 | 2020 |
| The design and manufacture of immediate-release optimal solid dosage forms AH Blaesi Massachusetts Institute of Technology, 2014 | 5 | 2014 |
| Gastroretentive fibrous dosage forms for prolonged delivery of sparingly soluble tyrosine kinase inhibitors. Part 1: Dosage form design, and models of in vitro expansion, post … AH Blaesi, N Saka International Journal of Pharmaceutics, 123428, 2023 | 4 | 2023 |
| Mechanical strength and gastric residence time of expandable fibrous dosage forms AH Blaesi, D Kümmerlen, H Richter, N Saka International journal of pharmaceutics 613, 120792, 2022 | 4 | 2022 |
| Gastroretentive fibrous dosage forms for prolonged delivery of sparingly soluble tyrosine kinase inhibitors. Part 3: Theoretical models of in vivo expansion, gastric residence … AH Blaesi, N Saka International journal of pharmaceutics 653, 123478, 2024 | 3* | 2024 |
